2,3,7,8-Tetrachlorodibenzo-p-dioxin
(TCDD) is the most toxic congener of a large class of toxic pollutants, collectively known as halogenated dioxins (1, 2) . The dioxins, together with the halogenated dibenzofurans, polychlorinated biphenyls, and polybrominated biphenyls, belong to a larger class of toxins collectively referred to as the halogenated aromatic hydrocarbons (HAHs). HAHs are characterized by a common set of toxic effects and biochemical changes, including immunosuppression, carcinogenesis, teratogenesis, and induction of cytochrome CYP1A1 and other components of xenobiotic detoxification enzyme systems. One of the most prominent symptoms of poisoning in many species is a marked loss of body weight called "wasting syndrome." In the guinea pig this wasting syndrome appears to be directly correlated to the lethal effects of TCDD (LD50 for males, 0.6 pg/kg) (3) . Associated with this wasting syndrome is a decrease in food intake and indications of malnourishment. Nevertheless, poisoned animals retain normal patterns of carbohydrate, lipid, and protein metabolism (4) . Initially it was hypothesized that TCDD reduced intestinal absorption of nutrients, and it was assumed that reduction of absorbed nutrients was responsible for weight loss. Nevertheless, administration of parenteral nutrition to poisoned animals, although increasing body weight, did not prevent them from dying (5) . Reduction of caloric intake in untreated animals to produce weight loss matching that of TCDD-treated animals did not produce the lethal effects seen in TCDD-poisoned animals (6). Peterson et al. (4) concluded that treated animals acquired a lower "set point" for maintenance of their body weight.
Recently we reported that TCDD inhibits glucose uptake in guinea pig adipose and guinea pig pancreatic tissue, both in vivo and in vitro, using isolated adipose and pancreas tissue culture (7, 8) . The inhibition of glucose uptake in adipose cells provides a plausible explanation for the loss of adipose tissue in vivo in TCDD-induced wasting syndrome. Adipose tissue contains low levels of glycerol kinase, which has been estimated in humans as being able to convert only 2.5-3.5% of the glycerol released from triglyceride breakdown and turnover into the 3-phosphoglycerol necessary for the reesterification of fatty acids to triglycerides (9) . The breakdown of glucose to generate 3-phosphoglycerol, therefore, serves as the key rate-limiting reaction for the overall lipogenic process in adipose tissue, with a loss of glucose uptake making the reesterification of fatty acids impossible, thus leading to the loss of stored triglycerides. Because CFor the 6.7 mM glucose concentration, TCDD's effect on 3H-Me-glc uptake was significantly decreased compared to the corresponding control (p < 0.05, two-tailed Student's t-test). "Differentiated cells were treated for 72-hr period with media containing 0.25 pM dexamethasone, 10 pg/ml insulin, and 0.5 mM methylisobutyl xanthene. Undifferentiated cells were grown to confluence in DMEM high glucose with 10% calf serum. Lipisomes are evident in the cells after treatment with the differentiating media.
b30-min incubation; means ± 1 SD; n = 3.
CFor experiments involving cyto-B (cytochalasin B), 70 pg of cytochalasin B in 10 pl of ethanol were added to each dish of cells and incubated for 1 hr before addition of TCDD in acetone or acetone alone (control) and then incubated for 3 hr before assay for glucose transport.
Glucose uptake assays employed 1 pCi of 3H-Me-glc and 13.3 mM cold glucose. Net uptake of 3H-MegIc is the nonspecific binding of 3H-Me-gIc determined by addition of cytochalasin B subtracted from corresponding control or TCDD values.
*Significantly different from control at p 0.05 (two-tailed Student's t-test).
integrations per minute was made based on quench curves.
After initial experiments (Table 1) , glucose uptake assays included determination of 3H-Me-glc nonspecific binding using a susceptibility test for cytochalasin B (Sigma, St Louis, MO) as follows. Cytochalasin B was administered to the cell monolayers by adding of 70 pg of cytochalasin B in 10 pl of absolute ethanol to each 60-mm plate 4 hr before glucose uptake assays. We added test compounds to the media 1 hr later (3 hr before glucose uptake assays) as described above. The portion of 3H-Me-glc uptake that was inhibited by this concentration of cytochalasin B was defined as the uptake activity through the glucose transporter proteins.
Cells were seeded on 60-mm plates and differentiated as described above. They were subsequently treated for 72 hr with either hormone alone or hormone plus 8 10-°M TCDD. Hormone concentrations in maintenance medium were 1 ng/ml tetraiodothyronine (T4), 10 ng/ml triiodothyronine (T3), 10 ng/ml tumor necrosis factor-a (TNFa), and 1 pg/ml of antibody against TNFa. Glucose uptake assays were performed as described above.
Results Table 1 total radioactivity recovered is 3H-Me-glc nonspecific binding. Accordingly, TCDDmediated inhibition of glucose uptake changes from about 10% for data not corrected for nonspecific binding to about 90% for data corrected for nonspecific binding (Table 2) . TCDD significantly reduced glucose uptake (p < 0.05, twotailed Student's t-test) for differentiated cells. For undifferentiated 3T3 LI cells the magnitude of TCDD-mediated reduction in glucose was less and was not significant at the p < 0.05 level. Figure 1 shows the results of a representative experiment to determine the dose response for TCDD-mediated inhibition of glucose uptake after a 3-hr incubation of 3T3 LI Table 3 indicate that this Ah receptor blocker actually increased glucose uptake. However, the effect ofTCDD was minimal in cells treated with 4,7-phenanthroline as compared to those untreated with this blocker. In Table 4 inhibit glucose uptake. As expected, TCDD was the most potent inhibitor of specific glucose uptake followed by 3,3,4,4' and 2,2',5,5'-tetrachlorobiphenyl (both tested at 10-7 M). The rank order of inhibition of glucose uptake matches the rank order for these compounds as Ah receptor agonists. The combined actions of TCDD and a series of different hormones on glucose uptake are presented in Table 5 . These glucose uptake assays were preformed on separate days using separate groups of differentiated adipocytes. Data presented in Table 5 are corrected for nonspecific binding of 3H-Me-glc. The thyroid hormones T and T4, TNFX, TCDD, and the antibody against TNFa all significantly (p < 0.05, two-tailed Student's t-test) reduced glucose uptake over control. T4 and the antibody against TNFa abolished the action of TCDD to further reduce glucose uptake. TNFa did not prevent a significant (p<0.05, two-tailed, Student's t-test) TCDD-induced reduction in glucose bThe combined action of TCDD and hormones was investigated in two separate series of experiments. Hormone concentrations in maintenance media were 1 pg/ml epidermal growth factor, 1 ng/ml T. 10 nglml T3, 10 ng/ml tumor necrosis factor-a (TNFa), and 1 pg/ml of antibody against TNFa. Cells were differentiated as described in Materials and Methods and then media changed. Maintenance media for treated cells contained 10.8 M TCDD with or without hormones, and cells were exposed to TCDD and hormones for 72 hr before the glucose uptake assay. Glucose uptake assay contained 1 pCi 3H-Me-glc plus 13 uptake; nevertheless, the magnitude of TCDD-mediated decrease was not as great as for control and TCDD alone groups.
Discussion
Understanding of the process of glucose transport and its regulation has rapidly advanced over the last several years (17, 18) . The NIH 3T3 LI preadipocyte cell line has served as a model system for investigations into glucose transport and was chosen for these investigations both for its widespread use as an in vitro model of adipose tissue function and because of its origin from TCDD-responsive Swiss albino mice. Initial experiments indicated TCDD inhibited glucose transport in 3T3 LI adipocytes (Table 1) . We have been interested in the key question of how TCDD is regulating glucose uptake and what types of glucose-transporting mechanisms TCDD affects. If cytochalasin B, a specific inhibitor of the facilitative glucose transporters GLUT 1 and GLUT 4 present in differentiated 3T3 LI cells (10, 19, 20) , and TCDD were acting on separate glucosetransport mechanisms, the affects of TCDD and cytochalasin B could be expected to be additive. However, they are not. The level of reduction of 3H-Me-glc uptake is always the same magnitude for both TCDD and cytochalasin B treatment, and it could not be decreased further by treatment of cells with a combination of both of these agents. When nonspecific binding of 3H-Me-glc was determined with cytochalasin B and corrected for, the inhibition of glucose uptake by TCDD became highly significant. 3H-Me-glc uptake values then changed from about 15% inhibition by TCDD to about 90% inhibition for values corrected for nonspecific binding.
TCDD consistently inhibited glucose transport in 3T3 Li adipocytes in a timeand dose-dependent manner, the effects of TCDD becoming statistically significant at a dose of 10-9 M (Fig. 1 ) and at 30 min (Fig. 2) . The total percent inhibition of glucose uptake did vary between experiments and may be related to two factors: state of differentiation and length oftime the cells were in culture after differentiation. The 3T3 LI cell line is propagated as an undifferentiated preadipocyte, which has a fibroblastlike morphology. The cells are induced to differentiate by adding high levels of insulin, dexamethasone and methylisobutyl xanthine to the cell media. We observed variation in the extent of differentiation of preadipocytes into adipocytes between different replicates of cells. For replicates containing larger numbers of fully differentiated cells (cells containing large lipid storage vacuoles), the values for specific glucose uptake were greater. Length of time in culture after differentiation of the cells may also have been a factor because insulin alters glucose transporter number and function (21) , and chronic treatment of 3T3 LI adipocytes with insulin results in the downregulation of the GLUT 4 in 3T3 LI cells (22) . For reasons discussed below, GLUT 4 may be important for the effects ofTCDD.
With regard to the nature of GLUT affected by TCDD, we compared the actions of TCDD in differentiated and undifferentiated cells to determine which of the two facilitative glucose transporters, GLUT 4 or GLUT 1, is affected by the actions of TCDD. In undifferentiated cells, GLUT 1 is the only glucose transporter present (19) , whereas differentiation of these cells by exposure to insulin, dexamethasone, and methylisobutyl xanthine causes the induction of the GLUT 4 form of the facilitative glucose transporter to levels higher than that of GLUT 1 (20) . When differentiated and undifferentiated cells were compared, the percent inhibition of glucose uptake by TCDD ( Table 1 are consistent with the idea that TCDD produces a greater reduction in the quantity of the low affinity, GLUT 4, form of the glucose transporter. Results in Table 2 show that GLUT 4 is more susceptible to the action of TCDD, though GLUT A --reduction in glucose uptake correlated with the relative affinity of several dioxin congeners toward the Ah receptor (7) . The similarity of the action pattern of TCDD to thyroid hormones (25) has already been noted. We were interested in examining the effect of thyroid hormones on glucose transport alone and in combination with TCDD to ascertain if these two agents might share a common mechanism in 3T3 L1 cells. We found that the thyroid hormones T3 and T4, like TCDD, significantly reduced glucose uptake in differentiated 3T3 LI cells (Table 5 ). In contrast, studies by Kuruvulla et al. (26) found that T3 stimulates glucose uptake and increases GLUT 1 mRNA in a nontransformed liver cell line, and studies by Casla et al. (27) found stimulation of glucose uptake and increased levels of GLUT 4 protein in muscles of hyperthyroid rats. However, these studies were in different tissues and, especially in the case of muscle tissue, hyperthyroidism increases general glucose requirements. Since hyperthyroidism reduces adipose tissue mass, differences in glucose transport between 3T3 LI cells and liver cells or muscle may be based on differences in organ responses to the thyroid hormones.
We did observe that T4, and to a lesser extent T3, antagonized the ability of TCDD to further reduce glucose uptake beyond the level already achieved by these thyroid hormones. Though these studies with hormones -do not prove that TCDD and any of the hormones are acting on the same site or through the same mechanism, they are consistent with observations that TCDD and the thyroid hormones share similar effects and might share some common biochemical mechanisms. Clearly, the titer of functionally active glucose transporter proteins are readily modulated by these hormone-type substances as well as TCDD.
In summary, the present study extends previous in vivo and in vitro work documenting the TCDD-mediated inhibition of glucose uptake (7, 8) . Furthermore, it has established the sensitivity of GLUT 4 to TCDD using the in vitro NIH 3T3 Li preadipocyte model system. Experimental evidence is consistent with TCDD inhibiting glucose uptake by regulation of GLUT 4 and, to a lesser extent, GLUT 1 through a mechanism involving the Ah receptor.
